Next quarter’s earnings estimate for AL21 is €0.32 with a range of €0.23 to €0.44. The previous quarter’s EPS was €0.20. AL21 beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 53.85% of the time in the same period. In the last calendar year AL21 has Outperformed its overall industry.

AL21 Sales Forecast

Next quarter’s sales forecast for AL21 is €162.29M with a range of €156.73M to €171.20M. The previous quarter’s sales results were ―. AL21 beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.69% of the time in the same period. In the last calendar year AL21 has Underperformed its overall industry.

Detailed List of Analyst Forecasts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Charles Rhyee

TD Cowen

€14.47

Buy

80.91%

Upside

Reiterated

09/10/24

Veradigm (MDRX) Gets a Buy from TD Cowen

George Hill

Deutsche Bank

€9.65

Hold

20.61%

Upside

Downgraded

03/18/24

Veradigm's Challenging Outlook: Hold Rating Justified Amid Revenue Growth, Margin Pressures, and Audit Concerns

Sean Dodge

RBC Capital

€10.61

Buy

32.67%

Upside

Reiterated

03/13/24

Analysts Conflicted on These Healthcare Names: Veradigm (Other OTC: MDRX), ADC Therapeutics (NYSE: ADCT) and Sangamo Biosciences (NASDAQ: SGMO)

Jessica Tassan

Piper Sandler

€10.61→€9.65

Hold

20.61%

Upside

Reiterated

01/17/24

Veradigm Inc (MDRX) PT Lowered to $10 at Piper SandlerPiper Sandler analyst Jessica Tassan lowered the price target on Veradigm Inc (NASDAQ: MDRX) to $10.00 (from $11.00) while maintaining a Neutral rating.

Stephanie Davis

Barclays

€10.61

Hold

32.67%

Upside

Initiated

01/02/24

Veradigm initiated with an Equal Weight at BarclaysVeradigm initiated with an Equal Weight at Barclays

Best Analysts Covering Veradigm

Which Analyst Should I Follow If I Want to Buy DE:AL21 and Sell After:

1 Month

xxx

Success Rate

10/26 ratings generated profit

Average Return

+2.85%

reiterated a xxx

rating 9 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 38.46% of your transactions generating a profit, with an average return of +2.85% per trade.

3 Months

xxx

Success Rate

22/26 ratings generated profit

Average Return

+10.12%

reiterated a xxx

rating 9 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 84.62% of your transactions generating a profit, with an average return of +10.12% per trade.

1 Year

Sean DodgeRBC Capital

Success Rate

18/26 ratings generated profit

Average Return

+23.99%

reiterated a buy rating 9 months ago

Copying Sean Dodge's trades and holding each position for 1 Year would result in 69.23% of your transactions generating a profit, with an average return of +23.99% per trade.

2 Years

xxx

Success Rate

11/26 ratings generated profit

Average Return

+10.58%

reiterated a xxx

rating 9 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 42.31% of your transactions generating a profit, with an average return of +10.58% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

AL21 Analyst Recommendation Trends

Rating

Jul 23

Jan 24

Mar 24

May 24

Sep 24

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, AL21 has received 3 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. AL21 average Analyst price target in the past 3 months is ―.

Each month's total comprises the sum of three months' worth of ratings.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

AL21 Stock Forecast FAQ

What is DE:AL21’s average 12-month price target, according to analysts?

Currently, no data Available

What is DE:AL21’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for DE:AL21, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Veradigm a Buy, Sell or Hold?

Currently, no data Available

What is Veradigm’s share price target?

Currently, no data Available

What do analysts say about Veradigm?

Not enough analysts have published a price target to provide an average price target.

How can I buy shares of Veradigm?

To buy shares of DE:AL21, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Veradigm (AL21) Stock Forecast & Price Target

AL21 Analyst Ratings

AL21 Stock 12 Month Forecast

AL21 Financial Forecast

AL21 Earnings Forecast

AL21 Sales Forecast

Detailed List of Analyst Forecasts​

Best Analysts Covering Veradigm

AL21 Analyst Recommendation Trends

AL21 Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts